Anavex Life Sciences Corp. Share Price
NASDAQ: AVXL | Micro CapAnavex Life Sciences Corp. Stock Performance
Open $3.33 | Prev. Close $3.29 | Circuit Range N/A |
Day Range $3.33 - $3.40 | Year Range $2.27 - $11.65 | Volume 46,103 |
Average Traded $3.37 |
Anavex Life Sciences Corp. Share Price Today
As of 10 August 2026, Anavex Life Sciences Corp.'s share price is $3.35. The stock opened at $3.33, compared to its previous close of $3.29. During today's trading session, Anavex Life Sciences Corp.'s share price traded between $3.33 and $3.40, with an average price of $3.36. Over the past 52 weeks, the stock has recorded a high of $11.65 and a low of $2.27. In terms of performance, Anavex Life Sciences Corp.'s share price has declined by 24.46% over the last six months and is down 65.28% on a year-on-year basis.
Anavex Life Sciences Corp. Share Price Chart
Anavex Life Sciences Corp. Stock Fundamentals & Key Indicators
Market Cap $285.72M | PE Ratio (TTM) -6.20 | Dividend Yield N/A |
EPS (TTM) $-0.54 | Revenue (TTM) N/A | Return On Equity (TTM) -48.89% |
Profit Margin N/A | Debt to Equity 0.09 | Quarterly Earnings Growth YoY 53.09% |
Anavex Life Sciences Corp. Quarterly Profit & Loss
All figures in USD
About Anavex Life Sciences Corp.
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States. The company's lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. It also provides ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. Anavex Life Sciences Corp. was incorporated in 2004 and is headquartered in New York, New York.
Anavex Life Sciences Corp. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $2.79 | $3.35 | +21.60% |
Jul 2026 | $2.62 | $2.75 | +6.58% |
Jun 2026 | $3.00 | $2.58 | -14.97% |
May 2026 | $3.34 | $3.04 | -9.12% |
Apr 2026 | $3.12 | $3.35 | +9.14% |
Mar 2026 | $4.48 | $3.06 | -30.89% |
Feb 2026 | $4.55 | $4.43 | -5.64% |
Jan 2026 | $3.60 | $4.70 | +31.65% |
Dec 2025 | $3.83 | $3.57 | -6.79% |
Nov 2025 | $7.89 | $3.83 | -51.88% |
Oct 2025 | $8.95 | $7.96 | -10.56% |
Sep 2025 | $9.58 | $8.90 | -7.77% |
AVXL Share Price FAQs
What is Anavex Life Sciences Corp. share price today?
What is the 52 week high and 52 week low of Anavex Life Sciences Corp. stock?
What is AVXL's market capitalisation today?
What is AVXL's net income for the last quarter?
What is the 5 year returns of AVXL?
What is the high & low stock price of AVXL today?
Can I buy AVXL shares in India?